A Study to Investigate the Safety and Tolerability of Ziftomenib Combinations in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510288-37-00

Acronym

KO-MEN-008

Enrollment

Registered

2024-08-22

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed and/or refractory Acute Myeloid Leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026